Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | PAM | P19021 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 4/20 | 0.41 |
| ▸ | CES1 | P23141 | 4/20 | 0.41 |
| ▸ | PRKCA | P17252 | 1/20 | 0.40 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.40 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31678974 | 0.98 | DGKA (0.53) | DGKAPAMTSHRMAPTLMNA | |
| SCHEMBL16669978 | 0.98 | DGKA (0.53) | DGKAPAMTSHRMAPTLMNA | |
| SCHEMBL8849362 | 0.85 | DGKA (0.53) | DGKAPAMTSHRMAPTLMNA | |
| SCHEMBL8848823 | 0.85 | DGKA (0.53) | DGKAPAMTSHRMAPTLMNA | |
| SCHEMBL1615758 | 0.84 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL15466818 | 0.81 | ALOX5 (0.35) | TSHRMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL8849127 | 0.79 | DGKA (0.38) | DGKAPAMTSHRMAPTLMNA | |
| SCHEMBL15654586 | 0.79 | NAAA (0.49) | DGKATSHRMAPTDNM1ALDH1A1 | |
| SCHEMBL245738 | 0.78 | DGKA (0.61) | DGKAPAMTSHRMAPTLMNA | |
| SCHEMBL855142 | 0.78 | DGKA (0.61) | DGKAPAMTSHRMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111620758-B | GAP-based thermoplastic propellant and preparation method thereof | 湖北三江航天江河化工科技有限公司 | 2022-01-18 | — | — | CN | claimed |
| CN-111620758-A | GAP-based thermoplastic propellant and preparation method thereof | 湖北三江航天江河化工科技有限公司 | 2020-09-04 | — | — | CN | claimed |
| CN-111592436-A | Low-vulnerability propellant and preparation method thereof | 湖北三江航天江河化工科技有限公司 | 2020-08-28 | — | — | CN | claimed |
| CN-120574137-A | Synthesis method of 2, 2-dinitropropyl caproate | 西安近代化学研究所 | 2025-09-02 | — | — | CN | disclosed |
| CN-120574137-A | Synthesis method of 2, 2-dinitropropyl caproate | 西安近代化学研究所 | 2025-09-02 | — | — | CN | disclosed |
| US-9227910-B2 | Gem-dinitro ester energetic material using esterification and preparation method thereof | AGENCY FOR DEFENCE DEVELOPMENT (KR) | 2016-01-05 | — | — | US | disclosed |
| US-9227910-B2 | Gem-dinitro ester energetic material using esterification and preparation method thereof | AGENCY FOR DEFENCE DEVELOPMENT (KR) | 2016-01-05 | — | — | US | disclosed |
| US-9227910-B2 | Gem-dinitro ester energetic material using esterification and preparation method thereof | AGENCY FOR DEFENCE DEVELOPMENT (KR) | 2016-01-05 | — | — | US | disclosed |
| US-20150119599-A1 | GEM-DINITRO ESTER ENERGETIC MATERIAL USING ESTERIFICATION AND PREPARATION METHOD THEREOF | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2015-04-30 | — | — | US | disclosed |
| US-20150119599-A1 | GEM-DINITRO ESTER ENERGETIC MATERIAL USING ESTERIFICATION AND PREPARATION METHOD THEREOF | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2015-04-30 | — | — | US | disclosed |
| US-20150119599-A1 | GEM-DINITRO ESTER ENERGETIC MATERIAL USING ESTERIFICATION AND PREPARATION METHOD THEREOF | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2015-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119599-A1 | GEM-DINITRO ESTER ENERGETIC MATERIAL USING ESTERIFICATION AND PREPARATION METHOD THEREOF | GMNN, GEMIN5, GEMIN4 | DGKA 228/4885PAM 259/4885TSHR 4621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.